期刊
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
卷 6, 期 5, 页码 601-618出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/14787210.6.5.601
关键词
ceftaroline; ceftobiprole; community-associated methicillin-resistant Staphylococcus aureus; dalbavancin; daptomycin; iclaprim; linezolid; methicillin-resistant S. aureus treatment; oritavancin; quinupristin-dalfopristin; telavancin; tigecycline; tomopenem
This review looks at the challenges facing the worldwide community with the increasing problem of methicillin resistance in Staphylococcus aureus. The epidemiology and natural history of community-associated methicillin-resistant Staphylococcus aureus and the challenge of control is discussed. Options for treatment and review of key antimicrobial agents acting against methicillin-resistant S. aureus, both currently in use and in development, are addressed. There are a number of new agents, the place of which in therapeutic regimens is yet to emerge. The review attempts to inform the reader of the probable position of these agents.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据